Drug profile · INN
abicipar pegol
RAYOQTA
abicipar pegol (RAYOQTA) is a vascular endothelial growth factor a inhibitor.
EMA: application withdrawn Sensory organs (S01) S01LA
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — abicipar pegol
- Class
- Sensory organs (S01)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
abicipar pegol (RAYOQTA) is a vascular endothelial growth factor a inhibitor.
Key facts
INN abicipar pegol
Brand RAYOQTA
Mechanism Vascular endothelial growth factor A inhibitor
Target Vascular endothelial growth factor A, long form
Therapeutic class Sensory organs (S01)
ATC code S01LA
Mechanism of action
Vascular endothelial growth factor A inhibitor
Primary target: Vascular endothelial growth factor A, long form
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | application withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is abicipar pegol?
abicipar pegol (RAYOQTA) is a vascular endothelial growth factor a inhibitor.
What is the brand name for abicipar pegol?
RAYOQTA is a marketed brand name for abicipar pegol. Check FDA Drugs@FDA for the current US label holder and prescribing information.